Litcius/Paper detail

Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease

Valeriya Pozdnyakova, Gregory J. Botwin, Kimia Sobhani, John C. Prostko, Jonathan Braun, Dermot McGovern, Gil Melmed, Keren Appel, Andrea Banty, Edward J. Feldman, Christina Ha, Rashmi Kumar, Susie Lee, Shervin Rabizadeh, Theodore Stein, Gaurav Syal, Stephan R. Targan, Eric Vasiliauskas, David Ziring, Philip Debbas, Melissa Hampton, Emebet Mengesha, James L. Stewart, Edwin C. Frias, Susan Cheng, Joseph E. Ebinger, Jane C. Figueiredo, Brigid S. Boland, Aline Charabaty, Michael Chiorean, Erica Cohen, Ann D. Flynn, Valentine John, David Fudman, Arash Horizon, Jason K. Hou, Caroline Hwang, Mark Lazarev, Donald Lum, Rebecca Fausel, Swapna Reddy, Mark Mattar, Mark Metwally, Arthur Ostrov, Nimisha Parekh, Laura H. Raffals, Sarah Sheibani, Corey A. Siegel, Douglas C. Wolf, Ziad Younes

2021Gastroenterology34 citationsDOIOpen Access PDF

Topics & Concepts

Inflammatory bowel diseaseMedicineAntibody responseCoronavirus disease 2019 (COVID-19)ImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseAntibodyInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesT-cell and B-cell Immunology